BioMarin Pharmaceuticals Inc vs Johnson & Johnson
BMRN vs JNJ — side-by-side comparison from reported financials. BMRN leads 2, JNJ leads 7 of 9 comparable metrics.
BioMarin Pharmaceuticals Inc
BMRN · Healthcare
$54.80-0.16%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | BMRN | JNJ |
|---|---|---|
| Price | $54.80 | $261.79 |
| Market cap | $10.6B | $631B |
| Revenue (TTM) | $3.41B | $97.9B |
| Revenue growth | +15.4% | +5.6% |
| Net margin | 2.1% | 21.5% |
| Free cash flow | $738M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +1.8% | +37.0% |
| P/E | 145.4 | 29.9 |
| P/E vs own history (cheap-side %) | 45% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 1% | 26% |
| Altman Z-score | 1.70 | — |
| CV checks passed | 8 of 10 | 10 of 10 |
| Employees | 3,221 | 140,800 |
Full résumé-style profiles: BMRN CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.